The Oncology Institute, Inc. TOI Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s common stock, shares, outstanding?
- The Oncology Institute, Inc. (TOI) reported common stock, shares, outstanding of $99.97M in Q1 2026.
- How has The Oncology Institute, Inc.'s common stock, shares, outstanding changed year-over-year?
- The Oncology Institute, Inc.'s common stock, shares, outstanding increased by 12.4% year-over-year, from $88.93M to $99.97M.
- What is the long-term trend for The Oncology Institute, Inc.'s common stock, shares, outstanding?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s common stock, shares, outstanding has grown at a 7.8% compound annual growth rate (CAGR), from $73.25M to $98.86M.